Close Menu

NEW YORK - NanoString Technologies reported after the close of the market on Tuesday that its total revenues declined 28 year over year as collaboration revenues shrank more than threefold.

For the three months ended June 30, total revenues came in at $25 million, down from $34.6 million a year ago when revenues were influenced by significant deferred influx from pharma collaborations.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The Washington Post reports that US states and territories are seeking more funding for the distribution of SARS-CoV-2 vaccines.

The strain now accounts for about 80 percent of cases in Wales and Scotland, and about half of cases in England, the Guardian reports.

A new study suggests that using CRISPR to edit human embryonic DNA can lead to the loss of whole chromosomes, as the Associated Press reports.

In Science this week: ancient dog genomes highlight long ties with humans, genomic analysis of 40,000-year-old early East Asian individual, and more.